Adalimumab induction therapy achieves clinical remission and response in Chinese patients with Crohn's disease

অনুরূপ উপাদানগুলি

• Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
  অনুযায়ী: Wu, K, অন্যান্য
  প্রকাশিত: (2016)
• Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn's disease
  অনুযায়ী: Jairath, V, অন্যান্য
  প্রকাশিত: (2016)
• Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.
  অনুযায়ী: Reenaers, C, অন্যান্য
  প্রকাশিত: (2013)
• Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?
  অনুযায়ী: Reenaers, C, অন্যান্য
  প্রকাশিত: (2012)
• Lymphoma risk and overall safety profile of Adalimumab in patients with Crohn's disease with up to 6 years of follow-up in the pyramid
  অনুযায়ী: D'Haens, G, অন্যান্য
  প্রকাশিত: (2018)